Some infections can raise a person’s risk of developing cancer. As reported on MedPage Today, global analysis estimates that about 2.3 million new cancer cases
As reported on Medical Daily, Artiva Biotherapeutics has discontinued development of its investigational autoimmune cell therapy, AlloNK, after two participant deaths occurred during a mid-stage
As reported by Science Daily, Researchers at Johns Hopkins have uncovered a long-sought explanation for how a toxin-producing gut bacterium contributes to colorectal cancer, identifying
Editor’s Note: This article was written and submitted to us by Pamela Mason, Patient Speaker & Advocate. Sometimes, the hardest part of a medical appointment
Changes in a group of genes called BAF may help cancer cells grow by altering how DNA is folded and which genes are switched on.
As reported on PharmaTimes, Merz Therapeutics has announced the completion of participant enrollment in two international Phase 3 clinical trials investigating XEOMIN (incobotulinumtoxinA) as a
AML is an aggressive cancer of the blood and bone marrow, that sometimes moves so quickly, that treatment cannot conquer it. Car-T cell therapy has
Editor’s Note: This article was written and submitted to us by Victoria Barghout, CEO and Founder Viver Health. Sixteen years ago, I was diagnosed with
As reported on ScienceDaily, researchers at the University of Virginia (UVA) have developed an experimental treatment strategy that could address two of the biggest challenges
Editor’s Note: This article was written by Wayne Eskridge, founder of the Fatty Liver Foundation. When we are diagnosed with F4 MASH (cirrhosis) we are
Editor’s Note: This story was submitted to Patient Worthy by Roger Templeman, Executive Director of Stabilize Revitalize Fort Pierce (SRFP), a grassroots nonprofit in Fort
According to recent international studies reported by MedicalXpress, the drug sac-TMT (sacituzumab tirumotecan) has been found to reduce recurrence or death from endometrial cancer. The
Calcinosis remains one of the most difficult complications to manage in patients with dermatomyositis (DM) and juvenile dermatomyositis (JDM), often causing pain, disability, and reduced
People often tell me how positive I am, and for the most part, I think that’s true. But after living with dystonia for more than
As reported by the Manila Times, the FDA has formally accepted uniQure’s biologics license application for ifezuntirgene inilparvovec (AMT-130), an experimental gene therapy being developed
My name is Jonathan Eskenas and I live in Los Angeles with my wife and our dogs. I’m an executive producer of television series and
As reported on PharmaBiz, a major UK breast cancer study has passed a significant recruitment milestone, with more than 1,000 patients now participating in research
In a collaborative effort between University College Institute (UCL) and the University of Cambridge, researchers have engineered personalized computational frameworks—often termed tumor “digital twins”—to forecast
No more posts
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
